Androgen insensitivity syndrome ultrasound: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 2: | Line 2: | ||
{{Androgen insensitivity syndrome}} | {{Androgen insensitivity syndrome}} | ||
{{CMG}}; {{AE}} {{ARK}} | {{CMG}}; {{AE}} {{ARK}} | ||
==Overview== | |||
Radiology findings shows impaired development of the prostate and of the wolffian duct derivatives. Also shows, determine presence or absence of uterus and gonads. | |||
==Ultrasound== | ==Ultrasound== | ||
Revision as of 01:11, 16 August 2017
|
Androgen insensitivity syndrome Microchapters |
|
Differentiating Androgen insensitivity syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Androgen insensitivity syndrome ultrasound On the Web |
|
American Roentgen Ray Society Images of Androgen insensitivity syndrome ultrasound |
|
Directions to Hospitals Treating Androgen insensitivity syndrome |
|
Risk calculators and risk factors for Androgen insensitivity syndrome ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]
Overview
Radiology findings shows impaired development of the prostate and of the wolffian duct derivatives. Also shows, determine presence or absence of uterus and gonads.
Ultrasound
- Radiology findings in the “predominantly male” phenotype including impaired development of the prostate and of the wolffian duct derivatives demonstrated by ultrasonography or genitourography. [1]
- Evaluation of neonatal ambiguity is described in more detail in the intersex article. It typically consists of pelvic ultrasound to determine presence or absence of uterus and gonads.